Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving online release in the journal Circulation: Cardiovascular Quality and Outcomes, a team of researchers reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
"Hospitals have put tremendous efforts in the past decade into increasing the number of patients who can be treated with intravenous tPA, and this paper suggests those efforts are paying off," says corresponding author Lee H. Schwamm, MD, executive vice chair of Neurology and director of Stroke Services at Massachusetts General Hospital (MGH) and professor of Neurology at Harvard Medical School.. "Today, more than three-quarters of stroke patients who are eligible for IV tPA are getting this treatment at the more than 1,600 U.S. hospitals we studied."
First introduced in 1996, intravenous tPA can be administered to patients with ischemic strokes – those caused by blockage of blood supply – if treatment can be started within a few hours of the onset of symptoms. When the drug was first introduced, the outer limit was set at 3 hours, and in 2009 it was extended to 4.5 hours. Appropriate use of tPA can reduce and sometimes even eliminate long-term disability due to a stroke, but the need to administer the drug within even the extended time window requires rapid transportation of patients to hospital emergency departments and quickly ruling out the possibility that the stroke is caused by bleeding into the brain, in which case tPA treatment would make it worse.
In 2003 the American Heart Association established Get With the Guidelines – Stroke (GWTG-S), a program designed to help hospitals organize stroke teams, establish best practices for treatment, share information with other member hospitals and measure their performance. The current study analyzed data on the treatment of 1.09 million acute ischemic stroke patients at 1,683 GWTG-S hospitals during the nine-year study period.
Among all patients who were admitted to the participating hospitals for ischemic stroke, usage of tPA increased from 4 percent in 2003 to 7 percent in 2011. In patients who arrived early and were without medical conditions that would prevent safe use of the drug, tPA administration increased from 43 percent to 77 percent. Since the researchers only analyzed data for patients arriving within 2 hours of symptom onset, the increased tPA usage was not due to expansion of the time window.
Study results also indicated more use of tPA to treat patients with less serious stroke symptoms, those aged 80 and over, and for black, Hispanic and other nonwhite patients. "We expect that this expansion happened because, as providers get comfortable using this drug and seeing good patient outcomes, they become more willing to treat all eligible patients and not just those they feel are the 'cream of the crop' for treatment," explains Schwamm, who also serves as the chair of the GWTG-S Clinical Workgroup.. He adds that, while it's possible that hospitals choosing to join GWTG-S might be more likely than others to offer the most advanced stroke treatment, the program has grown to the point where many U.S. patients have access to a GWTG-S hospital.
Despite the expansion in tPA usage revealed by the study, Schwamm stresses, the drug is still underutilized. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity. Patients and their loved ones need to recognize the signs of a stroke and get to the hospital quickly by calling 911, and hospitals need to be ready to provide rapid diagnosis and treatment. We hope that our results will encourage more hospitals to join GWTG-S or similar stroke quality improvement programs to help accelerate their use of tPA. When patients learn that their local hospitals are treating stroke more aggressively, that can translate into more awareness and faster action by the public."
Explore further: Certified stroke centers more likely to give clot-busting drugs
Medical Xpress on facebook
Related Stories
Certified stroke centers more likely to give clot-busting drugs
Mar 26, 2013
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association.
Study examines out-of hospital stroke policy at Chicago hospitals
Jul 01, 2013
Implementing an out-of hospital stroke policy in some Chicago hospitals was associated with significant improvements in emergency medical services use and increased intravenous tissue plasminogen activator (tPA) use at primary ...
Clot-busting drug safe for stroke patients taking blood thinner
May 10, 2012
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...
Timely treatment after stroke is crucial, researchers report
Jun 19, 2013
For years, the mantra of neurologists treating stroke victims has been "time equals brain." That's because getting a patient to the emergency room quickly to receive a drug that dissolves the stroke-causing blood clot can ...
Adding endovascular therapy to tPA didn't improve recovery after stroke
Feb 08, 2013
Adding endovascular therapy to clot-busting therapy for stroke did not significantly improve stroke recovery at three months, according to a study presented in a special symposium at the American Stroke Association's International ...
Recommended for you
Study aims to help patients with peripheral artery disease become more active
23 hours ago
For millions of Americans, simply walking to the mailbox can cause unbearable leg pain as muscles scream for more blood and oxygen.
Heart MRI test can identify patients at high risk of heart attack, death
Aug 20, 2013
An imaging test commonly used to diagnose coronary artery disease has an untapped potential to predict which patients with the disease are at the greatest risk for heart attacks and other potentially deadly heart problems, ...
Fruit-rich diet might lower aneurysm risk
Aug 20, 2013
(HealthDay)—Eating lots of fruit might decrease your risk of developing a dangerous abdominal aortic aneurysm, according to a large, long-running study.
Drug dosing for older heart patients should differ
Aug 16, 2013
Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients ...
Many stroke, heart-attack survivors make no changes after event
Aug 16, 2013
There's no stronger scare tactic into leading a healthy lifestyle than suffering a heart attack or stroke, which is why it may be surprising that many survivors don't make changes needed to improve their health.
High cholesterol riskier for middle-aged men than women
Aug 16, 2013
High cholesterol levels are much more risky for middle-aged men than middle-aged women when it comes to having a first heart attack, a new study of more than 40,000 Norwegian men and women has shown.
User comments
© Medical Xpress 2011-2013, Phys.org network
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving online release in the journal Circulation: Cardiovascular Quality and Outcomes, a team of researchers reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
"Hospitals have put tremendous efforts in the past decade into increasing the number of patients who can be treated with intravenous tPA, and this paper suggests those efforts are paying off," says corresponding author Lee H. Schwamm, MD, executive vice chair of Neurology and director of Stroke Services at Massachusetts General Hospital (MGH) and professor of Neurology at Harvard Medical School.. "Today, more than three-quarters of stroke patients who are eligible for IV tPA are getting this treatment at the more than 1,600 U.S. hospitals we studied."
First introduced in 1996, intravenous tPA can be administered to patients with ischemic strokes – those caused by blockage of blood supply – if treatment can be started within a few hours of the onset of symptoms. When the drug was first introduced, the outer limit was set at 3 hours, and in 2009 it was extended to 4.5 hours. Appropriate use of tPA can reduce and sometimes even eliminate long-term disability due to a stroke, but the need to administer the drug within even the extended time window requires rapid transportation of patients to hospital emergency departments and quickly ruling out the possibility that the stroke is caused by bleeding into the brain, in which case tPA treatment would make it worse.
In 2003 the American Heart Association established Get With the Guidelines – Stroke (GWTG-S), a program designed to help hospitals organize stroke teams, establish best practices for treatment, share information with other member hospitals and measure their performance. The current study analyzed data on the treatment of 1.09 million acute ischemic stroke patients at 1,683 GWTG-S hospitals during the nine-year study period.
Among all patients who were admitted to the participating hospitals for ischemic stroke, usage of tPA increased from 4 percent in 2003 to 7 percent in 2011. In patients who arrived early and were without medical conditions that would prevent safe use of the drug, tPA administration increased from 43 percent to 77 percent. Since the researchers only analyzed data for patients arriving within 2 hours of symptom onset, the increased tPA usage was not due to expansion of the time window.
Study results also indicated more use of tPA to treat patients with less serious stroke symptoms, those aged 80 and over, and for black, Hispanic and other nonwhite patients. "We expect that this expansion happened because, as providers get comfortable using this drug and seeing good patient outcomes, they become more willing to treat all eligible patients and not just those they feel are the 'cream of the crop' for treatment," explains Schwamm, who also serves as the chair of the GWTG-S Clinical Workgroup.. He adds that, while it's possible that hospitals choosing to join GWTG-S might be more likely than others to offer the most advanced stroke treatment, the program has grown to the point where many U.S. patients have access to a GWTG-S hospital.
Despite the expansion in tPA usage revealed by the study, Schwamm stresses, the drug is still underutilized. "We should be providing intravenous tPA to all eligible patients, which means that nearly a quarter of them are still missing that opportunity. Patients and their loved ones need to recognize the signs of a stroke and get to the hospital quickly by calling 911, and hospitals need to be ready to provide rapid diagnosis and treatment. We hope that our results will encourage more hospitals to join GWTG-S or similar stroke quality improvement programs to help accelerate their use of tPA. When patients learn that their local hospitals are treating stroke more aggressively, that can translate into more awareness and faster action by the public."
Explore further: Certified stroke centers more likely to give clot-busting drugs
Medical Xpress on facebook
Related Stories
Certified stroke centers more likely to give clot-busting drugs
Mar 26, 2013
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association.
Study examines out-of hospital stroke policy at Chicago hospitals
Jul 01, 2013
Implementing an out-of hospital stroke policy in some Chicago hospitals was associated with significant improvements in emergency medical services use and increased intravenous tissue plasminogen activator (tPA) use at primary ...
Clot-busting drug safe for stroke patients taking blood thinner
May 10, 2012
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...
Timely treatment after stroke is crucial, researchers report
Jun 19, 2013
For years, the mantra of neurologists treating stroke victims has been "time equals brain." That's because getting a patient to the emergency room quickly to receive a drug that dissolves the stroke-causing blood clot can ...
Adding endovascular therapy to tPA didn't improve recovery after stroke
Feb 08, 2013
Adding endovascular therapy to clot-busting therapy for stroke did not significantly improve stroke recovery at three months, according to a study presented in a special symposium at the American Stroke Association's International ...
Recommended for you
Study aims to help patients with peripheral artery disease become more active
23 hours ago
For millions of Americans, simply walking to the mailbox can cause unbearable leg pain as muscles scream for more blood and oxygen.
Heart MRI test can identify patients at high risk of heart attack, death
Aug 20, 2013
An imaging test commonly used to diagnose coronary artery disease has an untapped potential to predict which patients with the disease are at the greatest risk for heart attacks and other potentially deadly heart problems, ...
Fruit-rich diet might lower aneurysm risk
Aug 20, 2013
(HealthDay)—Eating lots of fruit might decrease your risk of developing a dangerous abdominal aortic aneurysm, according to a large, long-running study.
Drug dosing for older heart patients should differ
Aug 16, 2013
Older heart patients present unique challenges for determining the optimal dosages of medications, so a new study from researchers at Duke Medicine offers some rare clarity about the use of drugs that are used to treat patients ...
Many stroke, heart-attack survivors make no changes after event
Aug 16, 2013
There's no stronger scare tactic into leading a healthy lifestyle than suffering a heart attack or stroke, which is why it may be surprising that many survivors don't make changes needed to improve their health.
High cholesterol riskier for middle-aged men than women
Aug 16, 2013
High cholesterol levels are much more risky for middle-aged men than middle-aged women when it comes to having a first heart attack, a new study of more than 40,000 Norwegian men and women has shown.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment